-
Trophoblast Differentiation and Function (R21 Clinical Trial Optional)
(PA-18-047)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
(PA-18-048)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Eye Institute
National Institute of Neurological Disorders and Stroke
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional)
(PA-18-049)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Environmental Health Sciences
Office of Disease Prevention
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is June 16, 2017.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Optional)
(PA-18-052)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
International Research Collaboration on Drug Abuse and Addiction Research (R03 Clinical Trial Optional)
(PA-18-065)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Trial Optional)
(PA-18-066)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional)
(PA-18-067)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34 Clinical Trial Optional)
(PA-18-068)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03 Clinical Trial Optional)
(PA-18-069)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21 Clinical Trial Optional)
(PA-18-070)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Multiple dates, see announcement.
-
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 Clinical Trial Optional)
(PA-18-071)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
(PA-18-072)
National Institute on Drug Abuse
Application Receipt Date(s): Multiple dates, see announcement.
-
Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21 Clinical Trial Optional)
(PA-18-093)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional)
(PA-18-099)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
(PA-18-104)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Dietary Supplements
Application Receipt Date(s): Multiple dates, see announcement.
-
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
(PA-18-286)
National Cancer Institute
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
NIDCD Clinical Trials in Communication Disorders (R01-Clinical Trial Required)
(PA-18-334)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
(PA-18-358)
National Institute of Neurological Disorders and Stroke
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Addressing Health Disparities in NIDDK Diseases (R01 - Clinical Trial Not Allowed)
(PA-18-412)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
(PAR-18-018)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
(PAR-18-020)
National Cancer Institute
Application Receipt Date(s): February 20, 2018; June 19, 2018; October 17, 2018; February 20, 2019, by 5:00 PM local time of applicant organization.
-
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
(PAR-18-081)
National Institute on Drug Abuse
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional)
(PAR-18-082)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Optional)
(PAR-18-083)
National Institute on Drug Abuse
Application Receipt Date(s): July 20, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional)
(PAR-18-084)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional)
(PAR-18-085)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional)
(PAR-18-086)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pilot and Feasibility Clinical Research Grants in Kidney Diseases (R21 Clinical Trial Optional)
(PAR-18-100)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Pilot and Feasibility Clinical Research Grants in Urologic Disorders (R21 Clinical Trial Optional)
(PAR-18-101)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Multiple dates, see announcement.
-
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
(PAR-18-102)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
Limited Competition: Small Grant Program for NIDDK K01/K08/K23 Recipients (R03 Clinical Trial Optional)
(PAR-18-103)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
T1 Translational Research: Novel Interventions for Prevention and Treatment of Age-related Conditions (R21 Clinical Trial Optional)
(PAR-18-177)
National Institute on Aging
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization
-
T2 Translational Research: Research Leading to New Health Care Practices, Community Programs and Policies Affecting Older Persons (R21 Clinical Trial Optional)
(PAR-18-178)
National Institute on Aging
Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization.
-
Leveraging Electronic Health Records for Alcohol Services Research (R21/R33 Clinical Trial Optional)
(PAR-18-203)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
(PAR-18-207)
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
(PAR-18-227)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute of Biomedical Imaging and Bioengineering
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pilot Studies to Detect and Prevent Suicide Behavior, Ideation and Self-Harm in Youth in Contact with the Juvenile Justice System (R34 Clinical Trial Required)
(PAR-18-228)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pilot Services Research Grants Not Involving Interventions (R34 Clinical Trial Optional)
(PAR-18-267)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01-Clinical Trial Required)
(PAR-18-340)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): February 21, 2018, June 21,2018, October 22, 2018, February 21,2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed)
(PAR-18-346)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): January 23, 2018, January 23, 2019), by 5:00 PM local time of applicant organization. All types of non AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required)
(PAR-18-359)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required)
(PAR-18-360)
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54)
(PAR-18-361)
National Cancer Institute
Application Receipt Date(s): January 26, 2018; January 9, 2019; January 9, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed)
(PAR-18-364)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NCI Mentored Research Scientist Development Award to Promote Diversity (Parent K01 - Clinical Trial Required)
(PAR-18-365)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
(PAR-18-411)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): March 14, 2018; March 14, 2019; March 13, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mechanistic Basis of Diffuse White Matter Disease and Small Vessel Pathology in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01)
(PAR-18-413)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): March 23, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Pathogenesis of Age-Related HIV Neurodegeneration (R01 Clinical Trial Not Allowed)
(RFA-AG-18-023)
National Institute on Aging
Application Receipt Date(s): February 9, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Behavioral Interventions for Prevention of Opioid Use Disorder or Adjunct to Medication Assisted Treatment-SAMHSA Opioid STR Grants (R21/R33)
(RFA-AT-18-002)
National Center for Complementary and Integrative Health
Application Receipt Date(s): January 18, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement.
-
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
(RFA-CA-18-001)
National Cancer Institute
Application Receipt Date(s): February 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Shedding light on the dark genome: Long Non-coding RNA in Cardiovascular, Lung, Blood, and Sleep Research (R01 - Clinical Trial Not Allowed)
(RFA-HL-19-011)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): March 30, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Limited Competition: RCMI Research Coordination Network (RRCN) (U54)
(RFA-MD-18-001)
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 19, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01-Clinical Trial Required)
(RFA-MH-18-700)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01- Clinical Trial Required)
(RFA-MH-18-701)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018, October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)
(RFA-MH-18-702)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Early Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required)
(RFA-MH-18-703)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019, October 15, 2019, February 14, 2020, June 15, 2020, October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)
(RFA-MH-18-704)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33- Clinical Trial Required)
(RFA-MH-18-705)
National Institute of Mental Health
Application Receipt Date(s): New Dates February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)
(RFA-MH-18-706)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01- Clinical Trial Required)
(RFA-MH-18-707)
National Institute of Mental Health
Application Receipt Date(s): February 14, 2018, June 15, 2018; October 15, 2018, February 15, 2019, June 15, 2019; October 15, 2019, February 14, 2020, June 15, 2020; October 15, 2020; February 18, 2021 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.